OctoPlus Renamed Dr. Reddy's R&D

Dr. Reddy's Laboratories Ltd. has renamed its Dutch research center Octoplus, and affiliated legal entities of OctoPlus, to Dr. Reddy's Research and Development B.V.
 
OctoPlus develops long-acting injectables and liposomal pharmaceutical formulations. It was acquired by Dr. Reddy's in 2013 and became a fully integrated Centre of Excellence for the development of Dr. Reddy's complex injectables. Dr. Reddy's R&D, located in the Bio Science Park Leiden, is one of the two R&D centers based in Europe. The center has more than 100 employees.

"The renaming of our legal entity reflects our transformation from an external service provider into a seamlessly integrated R&D centre for Dr. Reddy's," said Roger Friedrich, general manager and site head, Dr. Reddy's Research and Development B.V. "Today we are focusing all our efforts on internal projects, working closely with the global development and manufacturing sites of Dr. Reddy's."